An important role for the ROS-modulated Kv1.3 [11] was instead well documented, both in cancer cells (for reviews see, e.g., [12,13]) and in some of the immune cells constituting the tumour microenvironment (TME) and actively modulating tumour progression [14]. This evidence concerns the gene KCNA3 and cancer.